Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Australia's largest smoking cessation trial uses Screen2Quit, a clinical app, to test digital tools' effectiveness in helping smokers quit.
Miroma Project Factory has developed Screen2Quit, a clinical-grade mobile app for Australia’s largest smoking cessation trial, part of the International Lung Screen Trial led by the University of Queensland.
Based on the My QuitBuddy platform, the app is used in a multi-year randomized controlled trial to assess whether app-based interventions outperform websites or control conditions in helping people quit smoking.
It features native iOS and Android versions, secure backends for data and forum moderation, and a unique trial ID system linking user behavior to anonymized clinical outcomes.
The app tracks engagement, navigation, and quit planning, supporting real-time research on digital behavior and cessation success.
Developed in two phases, it includes localization, a moderated forum, and ongoing technical support.
The trial, funded by the NHMRC and supported by Queensland Health, aims to evaluate the effectiveness of digital health tools in addressing smoking, a leading cause of preventable disease.
El ensayo más grande de Australia para dejar de fumar utiliza Screen2Quit, una aplicación clínica, para probar la eficacia de las herramientas digitales para ayudar a los fumadores a dejar de fumar.